NADPH oxidase 4 limits bone mass by promoting osteoclastogenesis.
about
Suppression of NADPH Oxidase Activity May Slow the Expansion of Osteolytic Bone MetastasesEvolution of NADPH Oxidase Inhibitors: Selectivity and Mechanisms for Target EngagementThe role of reactive oxygen species in mesenchymal stem cell adipogenic and osteogenic differentiation: a reviewReactive Oxygen-Related Diseases: Therapeutic Targets and Emerging Clinical IndicationsGenesis and growth of extracellular-vesicle-derived microcalcification in atherosclerotic plaques.Bone-associated gene evolution and the origin of flight in birdsAntioxidant Effect of Fructus Ligustri Lucidi Aqueous Extract in Ovariectomized Rats Is Mediated through Nox4-ROS-NF-κB PathwayNADPH oxidase 4 represents a potential target for the treatment of osteoporosis.LPS from P. gingivalis and hypoxia increases oxidative stress in periodontal ligament fibroblasts and contributes to periodontitisNox4 Is Dispensable for Exercise Induced Muscle Fibre Switchp47phox-Nox2-dependent ROS Signaling Inhibits Early Bone Development in Mice but Protects against Skeletal Aging.Ncf1 affects osteoclast formation but is not critical for postmenopausal bone loss.Cordycepin prevents oxidative stress-induced inhibition of osteogenesis.The NADPH oxidase Nox4 has anti-atherosclerotic functions.A novel pyrazole derivative protects from ovariectomy-induced osteoporosis through the inhibition of NADPH oxidase.Cordycepin Prevents Bone Loss through Inhibiting Osteoclastogenesis by Scavenging ROS Generation.NADPH oxidase gp91(phox) contributes to RANKL-induced osteoclast differentiation by upregulating NFATc1NOX4-dependent fatty acid oxidation promotes NLRP3 inflammasome activation in macrophages.Bone cell senescence: mechanisms and perspectives.Collagen modifications in postmenopausal osteoporosis: advanced glycation endproducts may affect bone volume, structure and quality.NADPH oxidases in bone homeostasis and osteoporosis.Advances and strategies in NADPH oxidase inhibitors and activators patents.Reactive oxygen species and oxidative stress in osteoclastogenesis, skeletal aging and bone diseases.APX-115, a first-in-class pan-NADPH oxidase (Nox) inhibitor, protects db/db mice from renal injury.Are reactive oxygen species still the basis for diabetic complications?Protein Thiol Redox Signaling in Monocytes and Macrophages.Therapeutic potential of NADPH oxidase 1/4 inhibitors.NOX4-derived reactive oxygen species limit fibrosis and inhibit proliferation of vascular smooth muscle cells in diabetic atherosclerosis.The effect of PDE5 inhibitors on bone and oxidative damage in ovariectomy-induced osteoporosis.Xanthotoxin prevents bone loss in ovariectomized mice through the inhibition of RANKL-induced osteoclastogenesis.Potein Kinase G Activation Reverses Oxidative Stress and Restores Osteoblast Function and Bone Formation in Male Mice With Type 1 Diabetes.Osteoimmunology: The Conceptual Framework Unifying the Immune and Skeletal Systems.The polymethoxy flavonoid sudachitin suppresses inflammatory bone destruction by directly inhibiting osteoclastogenesis due to reduced ROS production and MAPK activation in osteoclast precursors.Design, synthesis, and biological evaluation of inhibitors of the NADPH oxidase, Nox4.New Dual Fluorescent Probe for Simultaneous Biothiol and Phosphate Bioimaging.Glucose metabolism in bone.Deficits in Trabecular Bone Microarchitecture in Young Women With Type 1 Diabetes Mellitus.NoxO1 Controls Proliferation of Colon Epithelial Cells.
P2860
Q26738400-5C6F1D64-37EF-4CC6-8AA5-6C4603FA693CQ26861119-640FC454-0F4F-4F45-9009-E14D4662117EQ26996186-15223C35-A613-497E-8EE9-870E9E984B31Q27024762-1C49463E-D94C-4F8A-99EA-950E44D04584Q27314193-B8B52515-6B3F-4916-8B4D-76867ED8AB07Q28602600-81D5DACE-B4C2-4448-A3D3-566FD0C98786Q33710878-0426C318-BD16-4F48-9814-CF89F87B3148Q33858386-3F62586C-76D3-4587-B664-563AAE5ADF68Q34412657-5A6CDB87-A85C-4AB4-9008-363FA521AD66Q35666280-3CC3B952-77C5-4DB5-859D-1D346785D948Q35860848-28755E5F-F9B8-489A-AF84-86CC9552BBD5Q36187908-9E0AD6F4-CE75-4281-8BDB-C9CAB1434873Q36546401-D2B57D91-74C3-4BC5-9966-6A32BC643236Q36573517-F7E7BD6A-004A-40C0-A62D-DF05DF9B6B32Q36687909-089C73AB-B2B6-4270-88DF-4C543D3A3471Q36846350-A90F2872-A738-451E-AB6A-977A355D636EQ37448881-2F4FE34F-709D-472E-8D04-22D294259BDBQ37548406-2B4FDC07-EB72-45BA-A3BB-6DB9852A93BCQ38185298-C01E4C9F-736A-46E4-91CA-D620852299C6Q38216337-6AED9316-B072-467D-8D9A-A4622DA9E820Q38244251-004502E2-1D95-4E7F-8032-F6667816CA98Q38257747-F2D56A5D-AEBC-4124-93C7-754296065652Q38389210-76F9EC1A-76B1-4567-8137-AC955635E7FEQ38406031-A5A7D8E2-7AD5-4F16-BA1B-AC3F93B3CC78Q38451253-F9766C07-0CC3-468D-B526-D5B2B13298E6Q38854845-17DB7BDB-F821-4F87-94C1-0BC39E54AE64Q38858553-A7E2CC22-CAC4-4E4D-9EE1-4CFACFD91E5CQ42160197-5794E066-7FE1-4382-880B-9E403E7FC06EQ42989291-0323FDBC-7635-4956-93A9-3FE71F24A7F4Q46605120-367B6222-7CF6-4237-872A-3D19D1A80D45Q47231510-B5C53D23-91DC-4ECC-856E-DB1AA1C10B56Q47944184-1CB9B30C-0CE9-48F3-9C27-BFFC7D8579D5Q48226512-9E8DEFF2-7F38-451F-89C9-6D9676BAD972Q50092600-FC78BD6D-78E1-4E6F-88F3-2406AE9D250FQ50245438-6FB5F62F-1680-47EC-A7F2-FF29042FE666Q50428854-4F40B9A5-4C49-4CFC-A0D6-44225CF14D93Q50604480-80289AB2-648F-4D5C-BA64-DBED40438CD2Q54941451-00B3F3AC-C7CE-42E2-B9B4-B2F598139A26
P2860
NADPH oxidase 4 limits bone mass by promoting osteoclastogenesis.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
NADPH oxidase 4 limits bone mass by promoting osteoclastogenesis.
@en
NADPH oxidase 4 limits bone mass by promoting osteoclastogenesis.
@nl
type
label
NADPH oxidase 4 limits bone mass by promoting osteoclastogenesis.
@en
NADPH oxidase 4 limits bone mass by promoting osteoclastogenesis.
@nl
prefLabel
NADPH oxidase 4 limits bone mass by promoting osteoclastogenesis.
@en
NADPH oxidase 4 limits bone mass by promoting osteoclastogenesis.
@nl
P2093
P2860
P50
P356
P1476
NADPH oxidase 4 limits bone mass by promoting osteoclastogenesis
@en
P2093
Andrea Babelova
Barbara Obermayer-Pietsch
Lorenz C Hofbauer
Marian Kampschulte
Martina Rauner
Olivia Trummer
Reinhold G Erben
Sebastian Benkhoff
Stefan Rammelt
Valeska Weinberger
P2860
P304
P356
10.1172/JCI67603
P407
P577
2013-11-01T00:00:00Z